MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,781,853 | +49.6% | 33,953 | -5.2% | 0.03% | +47.6% |
| Q2 2020 | $1,191,399 | +27.4% | 35,810 | +4.1% | 0.02% | +5.0% |
| Q1 2020 | $935,408 | +52.7% | 34,390 | +10.8% | 0.02% | +100.0% |
| Q4 2019 | $612,597 | +47.6% | 31,049 | -3.0% | 0.01% | +42.9% |
| Q3 2019 | $414,992 | +6.1% | 32,021 | +1.9% | 0.01% | 0.0% |
| Q2 2019 | $391,241 | -14.3% | 31,425 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $456,605 | +57.1% | 31,425 | +19.3% | 0.01% | +33.3% |
| Q4 2018 | $290,694 | -55.9% | 26,331 | +5.0% | 0.01% | -50.0% |
| Q3 2018 | $659,341 | -99.9% | 25,070 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $512,681,000 | +12.7% | 25,070 | 0.0% | 0.01% | +33.3% |
| Q1 2018 | $455,020,000 | +132946.8% | 25,070 | +2.3% | 0.01% | +20.0% |
| Q4 2017 | $342,000 | -61.1% | 24,504 | -48.5% | 0.01% | -16.7% |
| Q3 2017 | $880,000 | +9.5% | 47,570 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $804,000 | +30.5% | 47,570 | +3.0% | 0.01% | +50.0% |
| Q1 2017 | $616,000 | -14.8% | 46,177 | -3.8% | 0.00% | -20.0% |
| Q4 2016 | $723,000 | +28.9% | 48,023 | 0.0% | 0.01% | +25.0% |
| Q3 2016 | $561,000 | +8.1% | 48,023 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $519,000 | +22.4% | 48,023 | +4.7% | 0.00% | +33.3% |
| Q1 2016 | $424,000 | -37.7% | 45,882 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $681,000 | +2.6% | 45,882 | +13.4% | 0.01% | 0.0% |
| Q3 2015 | $664,000 | -28.1% | 40,470 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $923,000 | +62.5% | 40,470 | +8.3% | 0.01% | +50.0% |
| Q1 2015 | $568,000 | +26.2% | 37,366 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $450,000 | +6.1% | 37,366 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $424,000 | -6.0% | 37,366 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $451,000 | +3.7% | 37,366 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $435,000 | -34.2% | 37,366 | 0.0% | 0.00% | -40.0% |
| Q4 2013 | $661,000 | +22.9% | 37,366 | 0.0% | 0.01% | +25.0% |
| Q3 2013 | $538,000 | -4.4% | 37,366 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $563,000 | – | 37,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |